|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net (Loss)/Income | |||||
| Depreciation and amortization | |||||
| Discount expensed from note payable and convertible notes | |||||
| Common stock issued for services | |||||
| Warrants issued for services | |||||
| Loss on extinguishment of debt | |||||
| Change in fair value on derivative liability | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Deposit | |||||
| Inventory | |||||
| Offering costs | |||||
| Cost in acquisition of Hyperion/OP&M | |||||
| Right of use asset, net | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Accrued interest payable | |||||
| Accrued interest payable - related party | |||||
| Lease liability - current | |||||
| Lease liability - long-term | |||||
| Net Cash provided by (used in) Operating Activities | |||||
| Cash Flows from Investing Activities | |||||
| Purchase of fixed assets | |||||
| Gain on sale of asset | |||||
| Fixed asset purchase | |||||
| Acquisition of Gummy USA LLC | |||||
| Cash flows provided by (used in) Investing Activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from issuance of common stock | |||||
| Payments for treasury stock | |||||
| Proceeds from issuance of convertible debt | |||||
| Payments for repayment of convertible debt | |||||
| Proceeds from issuance of noted payable | |||||
| Payments for repayment of notes payable | |||||
| Proceeds from issuance of noted payable - related party | |||||
| Payments for repayment of noted payable - related party | |||||
| Loan origination fees | |||||
| Net Cash provided by (used in) Financing Activities | |||||
| Increase (decrease) in cash | |||||
| Cash at beginning of period | |||||
| Cash at end of period | |||||
Loading...
